The government quashes a nasty stunt used by drug makers to keep prescription prices high
by Michael Hiltzik, Los Angeles Times
Feb 21, 2019
3 minutes
Most of the efforts out of Washington to fight rising drug prices amount to all-talk-no-action. But there's one government campaign that has worked - and that the government just expanded.
This is the government's attack on so-called pay-to-delay schemes, in which the marketer of a brand-name drug pays off generic drug makers to keep their competing products off the shelves, sometimes for years.
The Federal Trade Commission, which has scored a string of courtroom victories
You’re reading a preview, subscribe to read more.
Start your free 30 days